Application 022331
- Type
- NDA
- Sponsor
- CONCORDIA PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | JENLOGA | CLONIDINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | JENLOGA | CLONIDINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | KAPVAY | CLONIDINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 0.1MG | Yes | Yes |
| 004 | KAPVAY | CLONIDINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022331-001 | JENLOGA | CLONIDINE HYDROCHLORIDE | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | |
| N022331-002 | JENLOGA | CLONIDINE HYDROCHLORIDE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | |
| N022331-003 | KAPVAY | CLONIDINE HYDROCHLORIDE | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | |
| N022331-004 | KAPVAY | CLONIDINE HYDROCHLORIDE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022331-003 | KAPVAY | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022331-003 | KAPVAY | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022331-003 | KAPVAY | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022331-003 | KAPVAY | 0.1MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022331-003 | KAPVAY | 0.1MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022331-003 | KAPVAY | 0.1MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022331-003 | KAPVAY | 0.1MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022331-003 | KAPVAY | 0.1MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022331-003 | KAPVAY | 0.1MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022331-001 | JENLOGA | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-09-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022331-002 | JENLOGA | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-05-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022331-003 | KAPVAY | 0.1MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022331-004 | KAPVAY | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-09-28 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022331-003 | AB1 | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022331-003 | AB1 | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022331-003 | AB1 | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N022331-003 | AB1 | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N022331-003 | AB1 | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N022331-003 | AB1 | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022331-003 | AB1 | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022331-003 | AB1 | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N022331-003 | AB1 | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022331-003 | AB1 | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022331-003 | AB1 | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022331-003 | AB1 | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022331-003 | AB1 | 1 | ea99ee380514… |
| 2023-12-20 04:57 UTC | 2023-12 | N022331-003 | AB1 | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022331-003 | AB1 | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022331-003 | AB1 | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022331-003 | AB1 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022331-003 | AB1 | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N022331-003 | AB1 | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N022331-003 | AB1 | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022331-003 | AB1 | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N022331-003 | AB1 | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N022331-003 | AB1 | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022331-003 | AB1 | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 88a8db46-0fc9-48cd-b7cc-ac9c9cdea100 | 2023-01-27 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Asclemed USA, Inc. | e8c7aa08-1450-de68-e053-2995a90ad0b6 | 2022-09-16 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Proficient Rx LP | 33c68d5e-6a68-40fd-a326-bf36a7e01d5b | 2022-09-01 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Actavis Pharma, Inc. | a842ab83-3531-44dd-a8a8-64dd89e87026 | 2022-09-01 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Proficient Rx LP | 38680c1d-3929-40d5-bda9-4eea5693afca | 2022-08-01 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 2a5b46ec-4c16-48a5-9e58-8d28a3f21274 | 2022-06-27 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Aurobindo Pharma Limited | 2b75c20c-9dcc-4a63-854a-e9cdd2d7c1fb | 2022-06-08 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Duraclon | CLONIDINE HYDROCHLORIDE | Mylan Institutional LLC | 8c126bb8-732a-4949-8754-2f50b5543638 | 2021-03-17 | Boxed warning, Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Xiamen LP Pharmaceutical Co., Ltd. | 7676af27-4d8f-49c4-a50f-6b0892e73c8f | 2020-10-27 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Asclemed USA, Inc. | b60034a6-b8ba-4e54-9ef0-029965e67bc0 | 2020-10-24 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 00d1562d-b4eb-4d89-95de-0aacee7a82a5 | 2020-07-29 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Proficient Rx LP | c812012c-4b1d-40a4-8d4e-aaae2bf1c852 | 2019-10-01 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | e9b22c56-a3fc-46df-b745-11c4ac309a91 | 2017-05-03 | Warnings, Adverse reactions | CLONIDINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 59212-658 | Kapvay | clonidine hydrochloride | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-658 | Kapvay | clonidine hydrochloride | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-658 | Kapvay | clonidine hydrochloride | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-658 | Kapvay | clonidine hydrochloride | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-658 | Kapvay | clonidine hydrochloride | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-658 | Kapvay | clonidine hydrochloride | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-658 | Kapvay | clonidine hydrochloride | Concordia Pharmaceuticals Inc. | NDA | Current |
| 66993-776 | Clonidine hydrochloride extended-release | clonidine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-776 | Clonidine hydrochloride extended-release | clonidine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-776 | Clonidine hydrochloride extended-release | clonidine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 61848 | SUPPL | 2020-02-07 |
| 61838 | SUPPL | 2020-02-07 |
| 48433 | SUPPL | 2017-05-17 |
| 45195 | SUPPL | 2016-08-16 |
| 45130 | SUPPL | 2016-08-16 |
| 38587 | SUPPL | 2015-06-10 |
| 29606 | SUPPL | 2015-06-10 |
| 17250 | SUPPL | 2014-12-16 |
| 29605 | SUPPL | 2014-11-21 |
| 17249 | SUPPL | 2013-02-14 |
| 7246 | SUPPL | 2013-02-14 |
| 38586 | SUPPL | 2010-10-07 |
| 17248 | SUPPL | 2010-10-07 |
| 17247 | SUPPL | 2010-10-07 |
| 29604 | SUPPL | 2010-10-04 |
| 29603 | SUPPL | 2010-10-04 |
| 21995 | ORIG | 2009-11-10 |
| 38585 | ORIG | 2009-10-07 |
| 7245 | ORIG | 2009-10-07 |
| 66954 | ORIG | 1900-01-01 |
| 66953 | ORIG | 1900-01-01 |
| 66952 | ORIG | 1900-01-01 |
| 53219 | ORIG | 1900-01-01 |
| 53218 | ORIG | 1900-01-01 |
| 53216 | ORIG | 1900-01-01 |